Clinical trial
Anti-inflammatory Effects of Colchicine in Patients Undergoing Percutaneous Coronary Intervention: Inflammatory Marker Substudy of the Colchicine-PCI Trial
NCT01709981 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Anti-inflammatory Effects of Colchicine in Patients Undergoing Percutaneous Coronary Intervention: Inflammatory Marker Substudy of the Colchicine-PCI Trial
- Lead sponsor
- NYU Langone Health
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 30, 2013
- Completion date
- December 13, 2021
- Enrollment
- 280 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.